Apellis Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 12.72 M | $319.56 M | 36.92% | 10.09% |
| AVORO CAPITAL ADVISORS LLC | 03/16/2026 | 12.22 M | $307.02 M | 0.00% | 9.70% |
| VANGUARD GROUP INC | 01/29/2026 | 10.67 M | $268.15 M | 6.88% | 8.47% |
| MORGAN STANLEY | 02/13/2026 | 9.17 M | $230.43 M | -4.88% | 7.28% |
| DEEP TRACK CAPITAL, LP | 02/13/2026 | 7.75 M | $194.68 M | -3.13% | 6.15% |
| RTW INVESTMENTS, LP | 02/17/2026 | 7.67 M | $192.59 M | 100.00% | 6.08% |
| BLACKROCK, INC. | 02/12/2026 | 6.26 M | $157.25 M | -0.13% | 4.97% |
| STATE STREET CORP | 02/13/2026 | 4.61 M | $115.89 M | 14.26% | 3.66% |
| UBS GROUP AG | 01/29/2026 | 4.19 M | $105.16 M | 22.05% | 3.32% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 02/17/2026 | 4.14 M | $103.98 M | 43.83% | 3.28% |
| POLAR CAPITAL HOLDINGS PLC | 02/17/2026 | 3.71 M | $93.11 M | 39.86% | 2.94% |
| SIREN, L.L.C. | 02/13/2026 | 2.58 M | $64.77 M | 0.00% | 2.05% |
| ORBIMED ADVISORS LLC | 02/17/2026 | 2.43 M | $61.04 M | 4.58% | 1.93% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 2.28 M | $57.19 M | -49.26% | 1.81% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 2.03 M | $50.90 M | -2.28% | 1.61% |
| JENNISON ASSOCIATES LLC | 01/30/2026 | 1.50 M | $37.79 M | -65.40% | 1.19% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 1.39 M | $34.80 M | -7.92% | 1.10% |
| NORGES BANK | 02/10/2026 | 1.20 M | $30.10 M | 100.00% | 0.95% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 02/13/2026 | 1.18 M | $29.64 M | 181.92% | 0.94% |
| BANK OF NOVA SCOTIA | 02/13/2026 | 1.07 M | $26.88 M | -26.51% | 0.85% |
| LOGOS GLOBAL MANAGEMENT LP | 02/17/2026 | 1.00 M | $25.12 M | 0.00% | 0.79% |
| MARSHALL WACE, LLP | 02/13/2026 | 990.85 K | $24.89 M | 149.75% | 0.79% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 956.77 K | $24.03 M | -35.24% | 0.76% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 02/11/2026 | 951.72 K | $19.73 M | 53.31% | 0.76% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 946.46 K | $23.78 M | -29.56% | 0.75% |
| KYNAM CAPITAL MANAGEMENT, LP | 02/17/2026 | 908.61 K | $22.82 M | 12.37% | 0.72% |
| NORTHERN TRUST CORP | 02/17/2026 | 696.52 K | $17.50 M | 26.81% | 0.55% |
| NUVEEN, LLC | 02/12/2026 | 681.82 K | $17.13 M | 2.52% | 0.54% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 657.20 K | $16.51 M | 40.13% | 0.52% |
| CITADEL ADVISORS LLC | 02/17/2026 | 648.23 K | $16.28 M | 10.53% | 0.51% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 644.45 K | $16.19 M | -0.41% | 0.51% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 633.06 K | $15.90 M | -12.43% | 0.50% |
| CITIGROUP INC | 02/13/2026 | 622.16 K | $15.63 M | 39.82% | 0.49% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 602.70 K | $15.14 M | 0.38% | 0.48% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 597.67 K | $15.01 M | 175.33% | 0.47% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 589.60 K | $14.81 M | -17.85% | 0.47% |
| SG AMERICAS SECURITIES, LLC | 01/09/2026 | 567.05 K | $14.24 M | 35.85% | 0.45% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 562.36 K | $14.13 M | 123.10% | 0.45% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 557.59 K | $14.01 M | -42.66% | 0.44% |
| WOODLINE PARTNERS LP | 02/17/2026 | 542.98 K | $13.64 M | 0.00% | 0.43% |
| SIMPLIFY ASSET MANAGEMENT INC. | 02/09/2026 | 538.01 K | $13.51 M | 403.34% | 0.43% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 533.91 K | $13.41 M | 70.10% | 0.42% |
| FIRST TRUST ADVISORS LP | 02/13/2026 | 495.95 K | $12.46 M | 100.00% | 0.39% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/17/2026 | 461.19 K | $11.58 M | -53.52% | 0.37% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 449.68 K | $11.30 M | -1.56% | 0.36% |
| OSSIAM | 02/13/2026 | 431.78 K | $10.85 M | -22.34% | 0.34% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 390.88 K | $9.84 M | 7.55% | 0.31% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 02/13/2026 | 374.45 K | $9.41 M | 61.23% | 0.30% |
| 683 CAPITAL MANAGEMENT, LLC | 02/17/2026 | 330.00 K | $8.29 M | 14.58% | 0.26% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 02/13/2026 | 329.13 K | $8.31 M | 90.16% | 0.26% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Apellis Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 423 institutional investors and hedge funds held shares of Apellis Pharmaceuticals Inc. The most heavily invested institutionals were:
UBS Group AG: 6.21 M
DIMENSIONAL FUND ADVISORS LP: 1.34 M
ALPINE ASSOCIATES MANAGEMENT INC.: 864,000
CITIGROUP INC: 657,223
VANGUARD FIDUCIARY TRUST CO: 654,922
BNP PARIBAS ARBITRAGE, SNC: 584,192
100.29% of Apellis Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 142.30 M shares in the last 24 months. This purchase volume represents approximately $2.84 B in transactions.